O

Ocular Therapeutix

Hydrogel-based ocular drug delivery platform

Administrative Specialist - Finance & Operations

Accounts Payable/ReceivableConfirmed live in the last 24 hours
Full-timeBedford, MA, USA$69k - $76.5kIn-person

About the Job

Requirements

  • At least 2 years of experience processing expense reports is preferred, including knowledge of the Sunshine Act.
  • Experience with Concur or a similar expense platform is preferred but not required.
  • Proficiency in Microsoft Office, including Outlook, Excel, Word, and PowerPoint, is required.
  • Maintain discretion and confidentiality as necessary.

Responsibilities

  • Review and process employee expense reports in SAP Concur for accuracy, completeness, and compliance with company policy.
  • Verify required receipts and supporting documentation.
  • Identify policy exceptions and follow up with management to resolve discrepancies when needed.
  • Assist employees with questions regarding Concur, travel, and company policies.
  • Monitor expense report queues to ensure timely processing and approvals.
  • Communicate with approvers and employees to resolve outstanding items.
  • Maintain accurate records and support internal and external audit requests as needed.
  • Escalate system issues or policy questions to management when necessary.
  • Perform ad hoc projects and administrative tasks for the Finance team as needed.
  • Assist with corporate American Express program operations, including virtual credit cards, as needed.
  • Assist with Concur training for new employees during onboarding.
  • Assist with keeping training materials related to travel and expenses up to date.

Desired Qualifications

  • At least 2 years of experience processing expense reports, including knowledge of the Sunshine Act.
  • Experience with Concur or a similar expense platform.

About the Company

Ocular Therapeutix

Hydrogel-based ocular drug delivery platform

Ocular Therapeutix develops and commercializes eye therapies using a hydrogel-based drug-delivery platform. Its approach uses a biodegradable hydrogel that stays in the eye to release medicine over time, reducing the need for frequent eye drops or injections. The flagship product, DEXTENZA, is a corticosteroid insert placed by a physician after eye surgery to treat inflammation and pain, providing sustained local treatment. The company differentiates itself by offering a scalable platform that can be used to create a range of eye medications and devices for conditions such as glaucoma, retinal diseases (including wet AMD), and dry eye, rather than competing solely on one drug. Revenue comes from selling these products to physicians and surgical centers. The goal is to expand the hydrogel delivery platform into a broader pipeline of eye therapies to improve patient outcomes and adherence by delivering drugs where and when they are needed most.

Company size
201-500
Company stage
IPO
Headquarters
Bedford, MA
Founded
2006

Recently Posted Jobs

Explore more opportunities at Ocular Therapeutix

See more jobs